Multivariable analyses
| hs-CRP | hs-TnT | ||||||
| All, OR (95% CI) | No CAD, OR (95% CI) | CAD, OR (95% CI) | All, OR (95% CI) | No CAD, OR (95% CI) | CAD, OR (95% CI) | ||
| All | M1 | 1.11 (0.96 to 1.27) | 0.98 (0.78 to 1.21) | 1.21 (1.01 to 1.45) | 1.22 (1.06 to 1.41) | 1.39 (1.06 to 1.82) | 1.14 (0.96 to 1.35) |
| M2 | 1.06 (0.92 to 1.23) | 0.91 (0.72 to 1.14) | 1.13 (0.94 to 1.37) | 1.26 (1.09 to 1.46) | 1.39 (1.05 to 1.84) | 1.22 (1.02 to 1.46) | |
| M3 | 1.05 (0.90 to 1.22) | 0.88 (0.68 to 1.12) | 1.13 (0.93 to 1.37) | 1.24 (1.06 to 1.44) | 1.35 (1.01 to 1.80) | 1.21 (1.01 to 1.46) | |
| Men | M1 | 1.09 (0.89 to 1.33) | 0.83 (0.58 to 1.18) | 1.25 (0.97 to 1.60) | 1.27 (1.04 to 1.56) | 1.62 (1.04 to 2.53) | 1.15 (0.91 to 1.44) |
| M2 | 1.06 (0.86 to 1.31) | 0.70 (0.48 to 1.02) | 1.21 (0.93 to 1.59) | 1.36 (1.10 to 1.68) | 1.56 (1.00 to 2.43) | 1.31 (1.02 to 1.68) | |
| M3 | 1.06 (0.85 to 1.30) | 0.67 (0.45 to 1.00) | 1.21 (0.92 to 1.59) | 1.37 (1.10 to 1.70) | 1.51 (0.93 to 2.45) | 1.32 (1.03 to 1.70) | |
| Women | M1 | 1.12 (0.93 to 1.36) | 1.08 (0.82 to 1.43) | 1.17 (0.89 to 1.53) | 1.18 (0.96 to 1.44) | 1.27 (0.90 to 1.78) | 1.12 (0.87 to 1.45) |
| M2 | 1.08 (0.88 to 1.32) | 1.04 (0.76 to 1.41) | 1.11 (0.83 to 1.47) | 1.20 (0.97 to 1.48) | 1.29 (0.89 to 1.86) | 1.18 (0.90 to 1.56) | |
| M3 | 1.03 (0.83 to 1.29) | 1.04 (0.73 to 1.47) | 1.05 (0.77 to 1.44) | 1.15 (0.92 to 1.43) | 1.24 (0.85 to 1.80) | 1.14 (0.85 to 1.52) | |
| Surgery <5 years | M1 | 0.91 (0.64 to 1.28) | 0.80 (0.46 to 1.39) | 0.96 (0.59 to 1.55) | 1.58 (1.21 to 2.05) | 1.95 (1.24 to 3.08) | 1.34 (0.99 to 1.82) |
| M2 | 0.97 (0.69 to 1.36) | 0.86 (0.51 to 1.44) | 1.07 (0.63 to 1.84) | 1.65 (1.25 to 2.18) | 2.05 (1.24 to 3.41) | 1.53 (1.03 to 2.28) | |
| M3 | 0.96 (0.67 to 1.36) | 0.74 (0.39 to 1.43) | 1.06 (0.60 to 1.88) | 1.66 (1.24 to 2.21) | 2.01 (1.13 to 3.56) | 1.58 (1.06 to 2.35) | |
| Surgery ≥5 years | M1 | 1.17 (1.00 to 1.36) | 1.02 (0.80 to 1.31) | 1.27 (1.04 to 1.55) | 1.04 (0.86 to 1.26) | 1.01 (0.68 to 1.50) | 1.03 (0.82 to 1.29) |
| M2 | 1.09 (0.93 to 1.28) | 0.93 (0.71 to 1.21) | 1.16 (0.94 to 1.43) | 1.04 (0.85 to 1.27) | 0.89 (0.58 to 1.37) | 1.09 (0.86 to 1.37) | |
| M3 | 1.08 (0.91 to 1.27) | 0.94 (0.70 to 1.26) | 1.14 (0.92 to 1.42) | 1.01 (0.82 to 1.24) | 0.85 (0.54 to 1.35) | 1.06 (0.84 to 1.35) | |
Values are the ORs (95% CIs) for 1 (ln) SD increase (z-score) in the hs-CRP and hs-TnT levels, as indicated. Model 1 (M1) includes hs-CRP and hs-TnT; model 2 (M2) includes hs-CRP or hs-TnT plus glucose intolerance (yes/no), hypertension (yes/no), smoking (present or past/never), and Apo B/A1 ratio; model 3 (M3) includes model 2 plus BMI. Stratification for presence of CAD (yes/no), sex (men and women) and time between survey and surgery (less or more than 5 years).
Apo A1, Apolipoprotein A1; Apo B, Apolipoprotein B; BMI, body mass index; CAD, coronary artery disease; hs-CRP, high-sensitivity C reactive protein; hs-TnT, high-sensitivity troponin T.